Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Embecta Corporation (EMBC)
NASDAQ:EMBC
Holding EMBC?
Track your performance easily
Earnings Data
Report Date
Feb 18, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
$0.44Last Year’s EPS
$0.61Same Quarter Last Year
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 26, 2024
|% Change Since: 41.46%
|Next Earnings Date:Feb 18, 2025
Earnings Call Sentiment|Neutral
Embecta demonstrated strong execution and financial resilience in a challenging macro environment, including successful debt reduction and product launches. However, significant challenges remain with the discontinuation of the insulin patch pump program and expected pricing headwinds in 2025.Company Guidance
During the Embecta Q4 2024 earnings call, the company provided preliminary guidance for fiscal 2025, anticipating an adjusted constant currency revenue decline of 1% to 2.5%. They expect adjusted gross margins to be between 63.25% and 64.25%, a decrease attributed to a lack of the previous year's profit-in-inventory benefit. Adjusted operating margins are projected to be between 29% and 30%, with adjusted diluted earnings per share ranging from $2.70 to $2.90. Embecta anticipates adjusted EBITDA margins of 35.5% to 36.5%. The company plans to repay approximately $110 million in debt, aiming to reduce net leverage to around 3x by year-end.Strong Execution in Challenging Environment
Despite historic inflation, rising interest rates, geopolitical conflicts, and supply chain issues, Embecta exceeded 2024 financial expectations with an adjusted revenue growth rate of 1.3% and adjusted EBITDA margin of 31.4%, surpassing initial pre-spin expectations.
Debt Pay Down Initiative
Embecta initiated a multi-year debt pay down plan to enhance financial flexibility, including a proactive additional $25 million payment on Term Loan B debt before fiscal year-end.
GLP-1 Product Expansion
Embecta launched a small pack GLP-1 pen needle set in Germany, aiming to address the growing demand for pen-based GLP-1 administration. Plans are underway to expand this offering to additional markets.
---
EMBC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
EMBC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 26, 2024 | $14.30 | $18.56 | +29.79% |
| Aug 09, 2024 | $14.08 | $15.11 | +7.32% |
| May 09, 2024 | $9.97 | $13.74 | +37.81% |
| Feb 09, 2024 | $17.06 | $15.61 | -8.50% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Embecta Corporation (EMBC) report earnings?
Embecta Corporation (EMBC) is schdueled to report earning on Feb 18, 2025, TBA Not Confirmed.
What is Embecta Corporation (EMBC) earnings time?
Embecta Corporation (EMBC) earnings time is at Feb 18, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EMBC EPS forecast?
EMBC EPS forecast for the fiscal quarter 2025 (Q1) is $0.44.
---